2QJ2
 
 | | A Mechanistic Basis for Converting a Receptor Tyrosine Kinase Agonist to an Antagonist | | Descriptor: | Hepatocyte growth factor, SULFATE ION | | Authors: | Tolbert, W.D, Daugherty, J, Gao, C.-F, Xe, Q, Miranti, C, Gherardi, E, Vande Woude, G, Xu, H.E. | | Deposit date: | 2007-07-06 | | Release date: | 2007-09-18 | | Last modified: | 2023-08-30 | | Method: | X-RAY DIFFRACTION (1.81 Å) | | Cite: | A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist
Proc.Natl.Acad.Sci.Usa, 104, 2007
|
|
2QJ4
 | | A Mechanistic Basis for Converting a Receptor Tyrosine Kinase Agonist to an Antagonist | | Descriptor: | Hepatocyte growth factor, SULFATE ION | | Authors: | Tolbert, W.D, Daugherty, J, Gao, C.-F, Xe, Q, Miranti, C, Gherardi, E, Vande Woude, G, Xu, H.E. | | Deposit date: | 2007-07-06 | | Release date: | 2007-09-18 | | Last modified: | 2023-08-30 | | Method: | X-RAY DIFFRACTION (2.5 Å) | | Cite: | A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist
Proc.Natl.Acad.Sci.Usa, 104, 2007
|
|
5TO5
 | | Structure of the TPR oligomerization domain | | Descriptor: | Nucleoprotein TPR | | Authors: | Pal, K, Xu, Q, Zhou, X.E, Melcher, K, Xu, H.E. | | Deposit date: | 2016-10-16 | | Release date: | 2017-10-18 | | Last modified: | 2024-03-06 | | Method: | X-RAY DIFFRACTION (2.5 Å) | | Cite: | Structural Basis of TPR-Mediated Oligomerization and Activation of Oncogenic Fusion Kinases.
Structure, 25, 2017
|
|
5TO6
 | | Structure of the TPR oligomerization domain | | Descriptor: | Nucleoprotein TPR | | Authors: | Pal, K, Bandyopadhyay, A, Xu, Q, Zhou, X.E, Melcher, K, Xu, H.E. | | Deposit date: | 2016-10-16 | | Release date: | 2017-10-18 | | Last modified: | 2023-10-04 | | Method: | X-RAY DIFFRACTION (2.7 Å) | | Cite: | Structural Basis of TPR-Mediated Oligomerization and Activation of Oncogenic Fusion Kinases.
Structure, 25, 2017
|
|
5TO7
 | | Structure of the TPR oligomerization domain | | Descriptor: | Nucleoprotein TPR | | Authors: | Pal, K, Xu, Q, Zhou, X.E, Melcher, K, Xu, H.E. | | Deposit date: | 2016-10-16 | | Release date: | 2017-10-18 | | Last modified: | 2023-10-04 | | Method: | X-RAY DIFFRACTION (2.6 Å) | | Cite: | Structural Basis of TPR-Mediated Oligomerization and Activation of Oncogenic Fusion Kinases.
Structure, 25, 2017
|
|
5TVB
 | | Structure of the TPR oligomerization domain | | Descriptor: | Nucleoprotein TPR | | Authors: | Pal, K, Xu, Q, Zhou, X.E, Melcher, K, Xu, H.E. | | Deposit date: | 2016-11-08 | | Release date: | 2017-09-20 | | Last modified: | 2017-11-01 | | Method: | X-RAY DIFFRACTION (2.75 Å) | | Cite: | Structural Basis of TPR-Mediated Oligomerization and Activation of Oncogenic Fusion Kinases.
Structure, 25, 2017
|
|
3HMS
 | |
3HMT
 | |
3HMR
 | |
3HN4
 | |
3SP8
 | | Crystal structure of NK2 in complex with fractionated Heparin DP10 | | Descriptor: | (4R)-2-METHYLPENTANE-2,4-DIOL, (4S)-2-METHYL-2,4-PENTANEDIOL, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, ... | | Authors: | Recacha, R, Mulloy, B, Gherardi, E. | | Deposit date: | 2011-07-01 | | Release date: | 2012-07-04 | | Last modified: | 2023-09-13 | | Method: | X-RAY DIFFRACTION (1.86 Å) | | Cite: | Crystal structure of NK2 in complex with fractionated Heparin DP10
TO BE PUBLISHED
|
|
